Several studies using genome-wide molecular techniques have reported various degrees of genetic heterogeneity between primary tumours and their distant metastases. However, it has been difficult to discern patterns of dissemination owing to the limited number of patients and available metastases. Here, we use phylogenetic techniques on data generated using whole-exome sequencing and copy number profiling of primary and multiple-matched metastatic tumours from ten autopsied patients to infer the evolutionary history of breast cancer progression. We observed two modes of disease progression. In some patients, all distant metastases cluster on a branch separate from their primary lesion. Clonal frequency analyses of somatic mutations show tha...
Breast cancer is one of the leading causes of cancer mortality worldwide. Distant metastases are nea...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Cancer related mortality is almost always due to metastatic dissemination of the primary disease. Wh...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple ...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Purpose:; Paired primary breast cancers and metachronous metastases after adjuvant treatment are rep...
A.G.L. and J.H.R.F. were supported by a Cancer Research UK Program Grant to Simon Tavaré (C14303/A17...
Breast cancer is one of the leading causes of cancer mortality worldwide. Distant metastases are nea...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Cancer related mortality is almost always due to metastatic dissemination of the primary disease. Wh...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple ...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...
Purpose:; Paired primary breast cancers and metachronous metastases after adjuvant treatment are rep...
A.G.L. and J.H.R.F. were supported by a Cancer Research UK Program Grant to Simon Tavaré (C14303/A17...
Breast cancer is one of the leading causes of cancer mortality worldwide. Distant metastases are nea...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in ...